LONDON — The European Union has asked AstraZeneca to do more to respect its contract with the bloc, as concerns grow that the pharmaceutical firm is set to miss delivery targets once again.

It is not the first time the EU and the drugs giant have been at odds with each other. AstraZeneca had initially offered to distribute roughly 100 milliondoses of its Covid-19 jab before the end of March. However, the firm had to renegotiate this amount on the back of production issues to just 40 million.

The European Commission, the institution negotiating the vaccine contracts on behalf of the 27 member states, is now concerned that even this reduced amount will not be met.

"AstraZeneca vaccines delivery: I see efforts, but not 'best efforts.' That's not good enough yet for AstraZeneca to meet its Q1 obligations," Thierry Breton, the commissioner for the internal market, said on Twitter Thursday night.

More in category

5 Things to Know About IBM's Earnings Report
April 21, 2021The Motley Fool
5 Things to Know About IBM's Earnings Report
2 Reasons This COVID Vaccine Latecomer Could Gain Major Market Share
April 21, 2021The Motley Fool
2 Reasons This COVID Vaccine Latecomer Could Gain Major Market Share
3 Cheap Cathie Wood Stocks to Buy Right Now
April 21, 2021The Motley Fool
3 Cheap Cathie Wood Stocks to Buy Right Now
Columbus, Ohio police shoot and kill teenage girl waving a knife
April 21, 2021MarketWatch
Columbus, Ohio police shoot and kill teenage girl waving a knife
Juventus shares slump 10% after Super League plans collapse
April 21, 2021MarketWatch
Juventus shares slump 10% after Super League plans collapse
The ‘Red Wedding’ of soccer. How Twitter reacted to the European Super League’s dramatic collapse.
April 21, 2021MarketWatch
The ‘Red Wedding’ of soccer. How Twitter reacted to the European Super League’s dramatic collapse.
The Fed won’t taper until 2023 at the earliest, says former White House economist. Here’s why.
April 21, 2021MarketWatch
The Fed won’t taper until 2023 at the earliest, says former White House economist. Here’s why.
European stocks rebound from worst losses in four months, led by chipmaker ASML
April 21, 2021MarketWatch
European stocks rebound from worst losses in four months, led by chipmaker ASML
EU reaches major climate deal ahead of Biden climate summit
April 21, 2021MarketWatch
EU reaches major climate deal ahead of Biden climate summit
Johnson & Johnson vaccine ‘pause’ isn’t crimping confidence in the vaccination process, survey says
April 20, 2021MarketWatch
Johnson & Johnson vaccine ‘pause’ isn’t crimping confidence in the vaccination process, survey says
Exxon floats idea for $100 billion private-public carbon capture hub, largest of its kind
April 20, 2021MarketWatch
Exxon floats idea for $100 billion private-public carbon capture hub, largest of its kind
Biden to pledge halving U.S. greenhouse gases by 2030
April 20, 2021MarketWatch
Biden to pledge halving U.S. greenhouse gases by 2030
Opinion: There is a new normal for Netflix, and that is not necessarily a bad thing
April 20, 2021MarketWatch
Opinion: There is a new normal for Netflix, and that is not necessarily a bad thing
Netflix predicts worst quarter for streaming growth in its history, stock falls 9%
April 20, 2021MarketWatch
Netflix predicts worst quarter for streaming growth in its history, stock falls 9%
What is the European Super League, and why are soccer fans so upset about it?
April 19, 2021MarketWatch
What is the European Super League, and why are soccer fans so upset about it?
Young, healthy adults will be deliberately reinfected with COVID-19 to boost vaccine development
April 19, 2021MarketWatch
Young, healthy adults will be deliberately reinfected with COVID-19 to boost vaccine development
Here’s what else to watch for at Biden’s Earth Day summit
April 18, 2021MarketWatch
Here’s what else to watch for at Biden’s Earth Day summit
Netflix Earnings in 6 Must-See Metrics
April 21, 2021The Motley Fool
Netflix Earnings in 6 Must-See Metrics
Why Novavax Could Be the Biggest Winner From Johnson & Johnson's Vaccine Woes
April 21, 2021The Motley Fool
Why Novavax Could Be the Biggest Winner From Johnson & Johnson's Vaccine Woes
Here's the Dr. Fauci Statement That Could Mean Good News for Inovio
April 21, 2021The Motley Fool
Here's the Dr. Fauci Statement That Could Mean Good News for Inovio
3 Stocks for a Better Retirement
April 21, 2021The Motley Fool
3 Stocks for a Better Retirement